Victory Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Sell |
27,111
-296
| -1% | -$269 | ﹤0.01% | 2430 |
|
|
2025
Q1 | $12.4K | Buy |
27,407
+323
| +1% | +$146 | ﹤0.01% | 2447 |
|
|
2024
Q4 | $13.6K | Buy |
27,084
+3,219
| +13% | +$1.62K | ﹤0.01% | 2462 |
|
|
2024
Q3 | $21.6K | Sell |
23,865
-415
| -2% | -$376 | ﹤0.01% | 2436 |
|
|
2024
Q2 | $24.2K | Sell |
24,280
-390
| -2% | -$389 | ﹤0.01% | 2415 |
|
|
2024
Q1 | $36.5K | Buy |
24,670
+1,175
| +5% | +$1.74K | ﹤0.01% | 2398 |
|
|
2023
Q4 | $25.6K | Buy |
23,495
+4,265
| +22% | +$4.65K | ﹤0.01% | 2495 |
|
|
2023
Q3 | $22.7K | Buy |
19,230
+804
| +4% | +$949 | ﹤0.01% | 2441 |
|
|
2023
Q2 | $26K | Sell |
18,426
-428
| -2% | -$603 | ﹤0.01% | 2434 |
|
|
2023
Q1 | $28.3K | Sell |
18,854
-219
| -1% | -$329 | ﹤0.01% | 2487 |
|
|
2022
Q4 | $22.3K | Sell |
19,073
-7
| -0% | -$8 | ﹤0.01% | 2505 |
|
|
2022
Q3 | $22K | Sell |
19,080
-3,571
| -16% | -$4.12K | ﹤0.01% | 2622 |
|
|
2022
Q2 | $36K | Buy |
22,651
+241
| +1% | +$383 | ﹤0.01% | 2580 |
|
|
2022
Q1 | $27K | Sell |
22,410
-1,129
| -5% | -$1.36K | ﹤0.01% | 2632 |
|
|
2021
Q4 | $58K | Sell |
23,539
-574
| -2% | -$1.41K | ﹤0.01% | 2632 |
|
|
2021
Q3 | $61K | Sell |
24,113
-414
| -2% | -$1.05K | ﹤0.01% | 2672 |
|
|
2021
Q2 | $70K | Buy |
24,527
+1,133
| +5% | +$3.23K | ﹤0.01% | 2642 |
|
|
2021
Q1 | $55K | Sell |
23,394
-728
| -3% | -$1.71K | ﹤0.01% | 2662 |
|
|
2020
Q4 | $42K | Buy |
24,122
+1,233
| +5% | +$2.15K | ﹤0.01% | 2468 |
|
|
2020
Q3 | $21K | Sell |
22,889
-1,294
| -5% | -$1.19K | ﹤0.01% | 2433 |
|
|
2020
Q2 | $21K | Sell |
24,183
-25,637
| -51% | -$22.3K | ﹤0.01% | 2443 |
|
|
2020
Q1 | $42K | Buy |
+49,820
| New | +$42K | ﹤0.01% | 2839 |
|
|
2019
Q4 | – | Sell |
-25,867
| Closed | -$25K | – | 2966 |
|
|
2019
Q3 | $25K | Buy |
+25,867
| New | +$25K | ﹤0.01% | 2963 |
|